Axios @axios
Moderna announced that it is in the process of developing a new vaccine that combines a booster dose of its COVID-19 vaccine with a seasonal flu vaccine. Following the announcement, Moderna's shares jumped more than 5%. https://t.co/8XBjnYkzAY — PolitiTweet.org